Podcast
MSL Talk: Tom Caravela, Ike Ogbaa
How to leverage KOL relationships to achieve strategic objectives with Dr. Aoife O'Dwyer
Summary
My guest today is Aoife O Dwyer, Founder of MSL Consultant, and we discuss how to leverage KOL relationships to achieve strategic objectives.
In this episode:
- What made Aoife decide to become an MSL Consultant and what she likes best about her role
- Aoife’s advice to MSLs who want to demonstrate their value to their company
- Most important things for people to remember in KOL identifications and stakeholder mapping
- Tips on getting a KOL meeting
- How can an MSL deliver value in a KOL meeting
- How can an MSL plan for a KOL meeting
- How has COVID affected an MSL’s ability to provide value and what advice Aoife can give to MSLs in handling this crisis
- What skills are now mandatory for MSLs during and after the COVID crisis to provide value to their KOLs and to their organization
- How Aoife expects Pharma to change practices as a result of Covid-19
- Advice to MSLs to help aid in their success
MSL Consultant, KOL relationships, strategic objectives, stakeholder mapping, Pharma practices
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Ike Ogbaa
Podcast
MSL Talk: Tom Caravela, Bernadett Mamone
What I DO….How I BUILD Relationships
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO